Discover
EMA
Emera Incorporated
52.27
200 x undefined
100 x undefined
bid
ask
-
0.75
1.41%
150 @ 04:55 AM
54.99 +2.72 (5.20%)
| Ytd | 6.15% | |
| 1y | 13.56% |
52.18
day range
53.40
44.86
52 week range
54.06
| Open | 52.91 | Prev Close | 53.02 | Low | 52.18 | High | 53.40 | Mkt Cap | 15.99B |
| Vol | 93.01K | Avg Vol | 393.04K | EPS | 2.31 | P/E | 22.63 | Forward P/E | 19.95 |
| Beta | 0.45 | Short Ratio | 13.67 | Inst. Own | 55.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 05-01 | Earning | 08-07 | 50-d Avg | 52.36 | 200-d Avg | 50.23 | 1yr Est | 62.00 |
EMA News
gurufocus.com
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN
Johnson and Johnson presents new IMAAVYÂ (nipocalimab-aahu) data at European Academy of Neurology (E
gurufocus.com
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP)
gurufocus.com
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults w
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults w